Bendamustine/Rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bendamustine/Rituximab, covering 2023-09-14 to 2023-09-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia [Phase 2]